Ontology highlight
ABSTRACT:
SUBMITTER: Lin L
PROVIDER: S-EPMC4930244 | biostudies-literature | 2015 Mar
REPOSITORIES: biostudies-literature
Lin Luping L Sabnis Amit J AJ Chan Elton E Olivas Victor V Cade Lindsay L Pazarentzos Evangelos E Asthana Saurabh S Neel Dana D Yan Jenny Jiacheng JJ Lu Xinyuan X Pham Luu L Wang Mingxue M MM Karachaliou Niki N Cao Maria Gonzalez MG Manzano Jose Luis JL Ramirez Jose Luis JL Torres Jose Miguel Sanchez JM Buttitta Fiamma F Rudin Charles M CM Collisson Eric A EA Algazi Alain A Robinson Eric E Osman Iman I Muñoz-Couselo Eva E Cortes Javier J Frederick Dennie T DT Cooper Zachary A ZA McMahon Martin M Marchetti Antonio A Rosell Rafael R Flaherty Keith T KT Wargo Jennifer A JA Bivona Trever G TG
Nature genetics 20150209 3
Resistance to RAF- and MEK-targeted therapy is a major clinical challenge. RAF and MEK inhibitors are initially but only transiently effective in some but not all patients with BRAF gene mutation and are largely ineffective in those with RAS gene mutation because of resistance. Through a genetic screen in BRAF-mutant tumor cells, we show that the Hippo pathway effector YAP (encoded by YAP1) acts as a parallel survival input to promote resistance to RAF and MEK inhibitor therapy. Combined YAP and ...[more]